BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moriwaki H, Miwa Y, Tajika M, Kato M, Fukushima H, Shiraki M. Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun. 2004;313:405-409. [PMID: 14684176 DOI: 10.1016/j.bbrc.2003.07.016] [Cited by in Crossref: 127] [Cited by in F6Publishing: 114] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Suzuki K, Takikawa Y. Biomarkers Of Malnutrition In Liver Cirrhosis. In: Lakshman R, Preedy V, Ross Watson R, Srirajaskanthan R, editors. Nutrition, Diet Therapy, and the Liver. CRC Press; 2009. pp. 203-15. [DOI: 10.1201/9781420085501.sec3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Kuwahata M, Yoshimura T, Sawai Y, Amano S, Tomoe Y, Segawa H, Tatsumi S, Ito M, Ishizaki S, Ijichi C. Localization of polypyrimidine-tract-binding protein is involved in the regulation of albumin synthesis by branched-chain amino acids in HepG2 cells. J Nutr Biochem. 2008;19:438-447. [PMID: 17707630 DOI: 10.1016/j.jnutbio.2007.05.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
3 Takuma Y, Nouso K, Makino Y, Hayashi M, Takahashi H. Clinical trial: oral zinc in hepatic encephalopathy. Aliment Pharmacol Ther. 2010;32:1080-1090. [PMID: 20822500 DOI: 10.1111/j.1365-2036.2010.04448.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 56] [Article Influence: 6.0] [Reference Citation Analysis]
4 Hayashi M, Ikezawa K, Ono A, Okabayashi S, Hayashi Y, Shimizu S, Mizuno T, Maeda K, Akasaka T, Naito M, Michida T, Ueshima D, Nada T, Kawaguchi K, Nakamura T, Katayama K. Evaluation of the effects of combination therapy with branched-chain amino acid and zinc supplements on nitrogen metabolism in liver cirrhosis. Hepatol Res. 2007;37:615-619. [PMID: 17517070 DOI: 10.1111/j.1872-034x.2007.00095.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
5 Takata R, Nishikawa H, Enomoto H, Iwata Y, Ishii A, Miyamoto Y, Ishii N, Yuri Y, Hasegawa K, Nakano C, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S. Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease. Medicine (Baltimore) 2017;96:e8761. [PMID: 29310350 DOI: 10.1097/MD.0000000000008761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Xu F, Dai CL, Wu XM, Chu P. Overwhelming postsplenectomy infection due to Mycoplasma pneumoniae in an asplenic cirrhotic patient: case report. BMC Infect Dis. 2011;11:162. [PMID: 21651767 DOI: 10.1186/1471-2334-11-162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
7 Weir V, Reddy KR. Nonpharmacologic Management of Hepatic Encephalopathy. Clinics in Liver Disease 2020;24:243-61. [DOI: 10.1016/j.cld.2020.01.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Kuwahata M, Kido Y. Branched Chain Amino Acid Supplementation and Plasma Albumin. In: Rajendram R, Preedy VR, Patel VB, editors. Branched Chain Amino Acids in Clinical Nutrition. New York: Springer; 2015. pp. 159-68. [DOI: 10.1007/978-1-4939-1914-7_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Hanai T, Shiraki M, Imai K, Suetugu A, Takai K, Shimizu M. Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis. Nutrients 2020;12:E1915. [PMID: 32610446 DOI: 10.3390/nu12071915] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Hanai T, Shiraki M, Nishimura K, Ohnishi S, Imai K, Suetsugu A, Takai K, Shimizu M, Moriwaki H. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition. 2015;31:193-199. [PMID: 25441595 DOI: 10.1016/j.nut.2014.07.005] [Cited by in Crossref: 201] [Cited by in F6Publishing: 181] [Article Influence: 25.1] [Reference Citation Analysis]
11 Ishizu Y, Ishigami M, Kuzuya T, Honda T, Hayashi K, Ishikawa T, Hirooka Y, Goto H. Low skeletal muscle mass predicts early mortality in cirrhotic patients with acute variceal bleeding. Nutrition 2017;42:87-91. [DOI: 10.1016/j.nut.2017.06.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhu Y, Ni T, Lin J, Zhang C, Zheng L, Luo M. Long non-coding RNA H19, a negative regulator of microRNA-148b-3p, participates in hypoxia stress in human hepatic sinusoidal endothelial cells via NOX4 and eNOS/NO signaling. Biochimie 2019;163:128-36. [PMID: 31082428 DOI: 10.1016/j.biochi.2019.04.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
13 Huang KY, Ong SC, Wu CC, Hsu CW, Lin HC, Fang YK, Cheng WH, Huang PJ, Chiu CH, Tang P. Metabolic reprogramming of hydrogenosomal amino acids in Trichomonas vaginalis under glucose restriction. J Microbiol Immunol Infect 2019;52:630-7. [PMID: 29198954 DOI: 10.1016/j.jmii.2017.10.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
14 Zhang L, Yu Y, Dong L, Gan J, Mao T, Liu T, Li X, He L. Effects of moderate exercise on hepatic amino acid and fatty acid composition, liver transcriptome, and intestinal microbiota in channel catfish (Ictalurus punctatus). Comp Biochem Physiol Part D Genomics Proteomics 2021;40:100921. [PMID: 34607243 DOI: 10.1016/j.cbd.2021.100921] [Reference Citation Analysis]
15 Xu H, Ruan L, Chen C, Fan J, Chen J, Zhao W, Meng H, Liu W, Zhao W, Zheng Q, Liu Z, Wang J. Therapeutic assessment of fractions of Gastrodiae Rhizoma on chronic atrophic gastritis by 1H NMR-based metabolomics. Journal of Ethnopharmacology 2020;254:112403. [DOI: 10.1016/j.jep.2019.112403] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Shimizu M, Kubota M, Tanaka T, Moriwaki H. Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis. Int J Mol Sci. 2012;13:579-595. [PMID: 22312273 DOI: 10.3390/ijms13010579] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
17 Koreeda C, Seki T, Okazaki K, Ha-Kawa SK, Sawada S. Effects of late evening snack including branched-chain amino acid on the function of hepatic parenchymal cells in patients with liver cirrhosis. Hepatol Res. 2011;41:417-422. [PMID: 21518402 DOI: 10.1111/j.1872-034x.2011.00795.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Nishikawa H, Shiraki M, Hiramatsu A, Moriya K, Hino K, Nishiguchi S. Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria: Sarcopenia assessment criteria in liver disease. Hepatol Res 2016;46:951-63. [DOI: 10.1111/hepr.12774] [Cited by in Crossref: 197] [Cited by in F6Publishing: 201] [Article Influence: 32.8] [Reference Citation Analysis]
19 Nishikawa H, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Sarcopenia and Frailty in Liver Cirrhosis. Life (Basel) 2021;11:399. [PMID: 33925660 DOI: 10.3390/life11050399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Saeki C, Takano K, Oikawa T, Aoki Y, Kanai T, Takakura K, Nakano M, Torisu Y, Sasaki N, Abo M, Matsuura T, Tsubota A, Saruta M. Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis. BMC Musculoskelet Disord. 2019;20:615. [PMID: 31878909 DOI: 10.1186/s12891-019-2983-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
21 Nishikawa H, Enomoto H, Iwata Y, Kishino K, Shimono Y, Hasegawa K, Nakano C, Takata R, Ishii A, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S. Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis. Medicine (Baltimore) 2017;96:e5800. [PMID: 28099336 DOI: 10.1097/MD.0000000000005800] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
22 Fukushima H, Miwa Y, Shiraki M, Gomi I, Toda K, Kuriyama S, Nakamura H, Wakahara T, Era S, Moriwaki H. Oral branched-chain amino acid supplementation improves the oxidized/reduced albumin ratio in patients with liver cirrhosis. Hepatology Research 2007;37:765-70. [DOI: 10.1111/j.1872-034x.2007.00123.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
23 Kuroda H, Ushio A, Miyamoto Y, Sawara K, Oikawa K, Kasai K, Endo R, Takikawa Y, Kato A, Suzuki K. Effects of branched-chain amino acid-enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: a one-year prospective trial. J Gastroenterol Hepatol. 2010;25:1550-1555. [PMID: 20796154 DOI: 10.1111/j.1440-1746.2010.06306.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
24 Kitajima Y, Takahashi H, Akiyama T, Murayama K, Iwane S, Kuwashiro T, Tanaka K, Kawazoe S, Ono N, Eguchi T, Anzai K, Eguchi Y. Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis. J Gastroenterol. 2018;53:427-437. [PMID: 28741271 DOI: 10.1007/s00535-017-1370-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 10.8] [Reference Citation Analysis]
25 Kanekawa T, Nagai H, Kanayama M, Sumino Y. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy. Cancer Chemother Pharmacol 2014;74:899-909. [PMID: 25138286 DOI: 10.1007/s00280-014-2564-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
26 Yang J, He J, Cao H, Zhao X, Fu S, Lu H, Chen Y, Pan X, Li L. Correlation between plasma amino acid profiles and the various stages of hepatitis B infection. Eur J Clin Microbiol Infect Dis 2012;31:2045-52. [PMID: 22294098 DOI: 10.1007/s10096-011-1538-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
27 Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H; Long-Term Survival Study Group. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol. 2005;3:705-713. [PMID: 16206505 DOI: 10.1016/s1542-3565(05)00017-0] [Cited by in Crossref: 336] [Cited by in F6Publishing: 112] [Article Influence: 19.8] [Reference Citation Analysis]
28 Shimizu M, Shirakami Y, Hanai T, Imai K, Suetsugu A, Takai K, Shiraki M, Moriwaki H. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids. Mol Nutr Food Res 2014;58:124-35. [PMID: 24273224 DOI: 10.1002/mnfr.201300538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
29 Tokuchi Y, Suda G, Kimura M, Maehara O, Kitagataya T, Kubo A, Yoshida S, Fu Q, Yang Z, Hosoda S, Ohara M, Yamada R, Suzuki K, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Ohnishi S, Sakamoto N. Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals. Sci Rep 2021;11:16616. [PMID: 34400736 DOI: 10.1038/s41598-021-96203-z] [Reference Citation Analysis]
30 Kida Y. Estimation of protein intake using urinary urea nitrogen in patients with liver cirrhosis. Scand J Gastroenterol. 2009;44:615-618. [PMID: 19137458 DOI: 10.1080/00365520802699252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Corrêa FCCR, Mira PAC, Pace FHL, Laterza MC, Trevizan PF, Martinez DG. REDUCED PERIPHERAL AND INSPIRATORY MUSCLE ENDURANCE IN PATIENTS WITH LIVER CIRRHOSIS: A CROSS-SECTIONAL STUDY. Arq Gastroenterol 2021;58:308-15. [PMID: 34705964 DOI: 10.1590/S0004-2803.202100000-53] [Reference Citation Analysis]
32 Setoyama H, Tanaka M, Nagumo K, Naoe H, Watanabe T, Yoshimaru Y, Tateyama M, Sasaki M, Watanabe H, Otagiri M, Maruyama T, Sasaki Y. Oral branched-chain amino acid granules improve structure and function of human serum albumin in cirrhotic patients. J Gastroenterol 2017;52:754-65. [PMID: 27873095 DOI: 10.1007/s00535-016-1281-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
33 Kotoh K, Nakamuta M, Fukushima M, Matsuzaki C, Enjoji M, Sakai H, Nawata H. High relative fat-free mass is important for maintaining serum albumin levels in patients with compensated liver cirrhosis. World J Gastroenterol 2005; 11(9): 1356-1360 [PMID: 15761975 DOI: 10.3748/wjg.v11.i9.1356] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
34 Nishikawa H, Shiraki M, Hiramatsu A, Hara N, Moriya K, Hino K, Koike K. Reduced handgrip strength predicts poorer survival in chronic liver diseases: A large multicenter study in Japan. Hepatol Res 2021;51:957-67. [PMID: 34057800 DOI: 10.1111/hepr.13679] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Kida Y, Ueda H, Tanaka H, Ichinose M. Estimation of protein intake using urinary urea nitrogen in patients with early-stage liver cirrhosis. Hepatol Int 2007;1:382-6. [PMID: 19669333 DOI: 10.1007/s12072-007-9019-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
36 Kawaguchi T, Izumi N, Charlton MR, Sata M. Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology. 2011;54:1063-1070. [PMID: 21563202 DOI: 10.1002/hep.24412] [Cited by in Crossref: 191] [Cited by in F6Publishing: 173] [Article Influence: 17.4] [Reference Citation Analysis]
37 Toshikuni N, Arisawa T, Tsutsumi M. Nutrition and exercise in the management of liver cirrhosis. World J Gastroenterol 2014; 20(23): 7286-7297 [PMID: 24966599 DOI: 10.3748/wjg.v20.i23.7286] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
38 Wada Y, Takeda Y, Kuwahata M. Potential Role of Amino Acid/Protein Nutrition and Exercise in Serum Albumin Redox State. Nutrients 2017;10:E17. [PMID: 29295548 DOI: 10.3390/nu10010017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
39 Hayaishi S, Chung H, Kudo M, Ishikawa E, Takita M, Ueda T, Kitai S, Inoue T, Yada N, Hagiwara S. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis. Dig Dis. 2011;29:326-332. [PMID: 21829025 DOI: 10.1159/000327571] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
40 Lam VW, Poon RT. Role of branched-chain amino acids in management of cirrhosis and hepatocellular carcinoma. Hepatol Res 2008;38 Suppl 1:S107-15. [PMID: 19125941 DOI: 10.1111/j.1872-034X.2008.00435.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
41 Nishikawa H, Osaki Y, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Henmi S, Sakamoto A, Ishikawa T, Saito S, Kita R, Kimura T. Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2012; 18(12): 1379-1384 [PMID: 22493552 DOI: 10.3748/wjg.v18.i12.1379] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
42 Terakura D, Shimizu M, Iwasa J, Baba A, Kochi T, Ohno T, Kubota M, Shirakami Y, Shiraki M, Takai K, Tsurumi H, Tanaka T, Moriwaki H. Preventive effects of branched-chain amino acid supplementation on the spontaneous development of hepatic preneoplastic lesions in C57BL/KsJ-db/db obese mice. Carcinogenesis 2012;33:2499-506. [PMID: 23027617 DOI: 10.1093/carcin/bgs303] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
43 Kawaguchi T, Sata M. Importance of hepatitis C virus-associated insulin resistance: Therapeutic strategies for insulin sensitization. World J Gastroenterol 2010; 16(16): 1943-1952 [PMID: 20419831 DOI: 10.3748/wjg.v16.i16.1943] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
44 Ichikawa T, Naota T, Miyaaki H, Miuma S, Isomoto H, Takeshima F, Nakao K. Effect of an oral branched chain amino acid-enriched snack in cirrhotic patients with sleep disturbance. Hepatol Res. 2010;40:971-978. [PMID: 20887332 DOI: 10.1111/j.1872-034x.2010.00701.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
45 Fallahzadeh MA, Rahimi RS. Hepatic Encephalopathy and Nutrition Influences: A Narrative Review. Nutr Clin Pract 2020;35:36-48. [PMID: 31872484 DOI: 10.1002/ncp.10458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
46 Saeki C, Kanai T, Nakano M, Oikawa T, Torisu Y, Abo M, Saruta M, Tsubota A. Relationship between Osteosarcopenia and Frailty in Patients with Chronic Liver Disease. J Clin Med 2020;9:E2381. [PMID: 32722566 DOI: 10.3390/jcm9082381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
47 Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabatake S, Yama T. Impact of the branched-chain amino acid to tyrosine ratio and branched-chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis: BTR and BCAA in HCC patients. J Gastroenterol Hepatol 2015;30:1412-9. [DOI: 10.1111/jgh.12954] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
48 Okabayashi T, Nishimori I, Sugimoto T, Maeda H, Dabanaka K, Onishi S, Kobayashi M, Hanazaki K. Effects of branched-chain amino acids-enriched nutrient support for patients undergoing liver resection for hepatocellular carcinoma. J Gastroenterol Hepatol. 2008;23:1869-1873. [PMID: 18717761 DOI: 10.1111/j.1440-1746.2008.05504.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
49 Toshikuni N, Arisawa T, Tsutsumi M. Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortality. World J Gastroenterol 2014; 20(11): 2876-2887 [PMID: 24659879 DOI: 10.3748/wjg.v20.i11.2876] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
50 Okabayashi T, Iyoki M, Sugimoto T, Kobayashi M, Hanazaki K. Oral supplementation with carbohydrate- and branched-chain amino acid-enriched nutrients improves postoperative quality of life in patients undergoing hepatic resection. Amino Acids. 2011;40:1213-1220. [PMID: 20852905 DOI: 10.1007/s00726-010-0748-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
51 Kumar U, Sharma S, Durgappa M, Gupta N, Raj R, Kumar A, Sharma PN, Krishna VP, Kumar RV, Guleria A, Saraswat VA, Pande G, Kumar D. Serum Metabolic Disturbances Associated with Acute-on-chronic Liver Failure in Patients with Underlying Alcoholic Liver Diseases: An Elaborative NMR-based Metabolomics Study. J Pharm Bioallied Sci 2021;13:276-82. [PMID: 34349490 DOI: 10.4103/JPBS.JPBS_333_20] [Reference Citation Analysis]
52 Kimura M, Ogihara M. Effects of branched-chain amino acids on DNA synthesis and proliferation in primary cultures of adult rat hepatocytes. European Journal of Pharmacology 2005;510:167-80. [DOI: 10.1016/j.ejphar.2005.01.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
53 Ashikawa H, Adachi T, Ueyama J, Yamada S. Association between redox state of human serum albumin and exercise capacity in older women: A cross-sectional study. Geriatr Gerontol Int 2020;20:256-60. [PMID: 31854142 DOI: 10.1111/ggi.13849] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
54 Kuwahata M, Kubota H, Katsukawa M, Ito S, Ogawa A, Kobayashi Y, Nakamura Y, Kido Y. Effect of branched-chain amino acid supplementation on the oxidized/reduced state of plasma albumin in rats with chronic liver disease. J Clin Biochem Nutr. 2012;50:67-71. [PMID: 22247603 DOI: 10.3164/jcbn.11-37] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
55 Furuichi Y, Imai Y, Miyata Y, Sugimoto K, Sano T, Taira J, Kojima M, Kobayashi Y, Nakamura I, Moriyasu F. Branched-chain amino acid-enriched nutrient increases blood platelet count in patients after endoscopic injection sclerotherapy: BCAA increases platelet count. Hepatol Res 2016;46:1129-36. [DOI: 10.1111/hepr.12668] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
56 Mayr U, Pfau J, Lukas M, Bauer U, Herner A, Rasch S, Schmid RM, Huber W, Lahmer T, Batres-Baires G. NUTRIC and Modified NUTRIC are Accurate Predictors of Outcome in End-Stage Liver Disease: A Validation in Critically Ill Patients with Liver Cirrhosis. Nutrients 2020;12:E2134. [PMID: 32709104 DOI: 10.3390/nu12072134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Montgomery J, Englesbe M. Sarcopenia in Liver Transplantation. Curr Transplant Rep 2019;6:7-15. [PMID: 31595213 DOI: 10.1007/s40472-019-0223-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
58 Kikuchi Y, Hiroshima Y, Matsuo K, Kawaguchi D, Murakami T, Yabushita Y, Endo I, Taguri M, Koda K, Tanaka K. A Randomized Clinical Trial of Preoperative Administration of Branched-Chain Amino Acids to Prevent Postoperative Ascites in Patients with Liver Resection for Hepatocellular Carcinoma. Ann Surg Oncol 2016;23:3727-35. [PMID: 27338747 DOI: 10.1245/s10434-016-5348-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
59 Minemura M, Tajiri K, Shimizu Y. Systemic abnormalities in liver disease. World J Gastroenterol 2009; 15(24): 2960-2974 [PMID: 19554648 DOI: 10.3748/wjg.15.2960] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
60 Takeshita S, Ichikawa T, Nakao K, Miyaaki H, Shibata H, Matsuzaki T, Muraoka T, Honda T, Otani M, Akiyama M, Miuma S, Ozawa E, Fujimito M, Eguchi K. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. Nutr Res. 2009;29:89-93. [PMID: 19285598 DOI: 10.1016/j.nutres.2008.12.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
61 Miyazaki T, Honda A, Ikegami T, Iwamoto J, Monma T, Hirayama T, Saito Y, Yamashita K, Matsuzaki Y. Simultaneous quantification of salivary 3-hydroxybutyrate, 3-hydroxyisobutyrate, 3-hydroxy-3-methylbutyrate, and 2-hydroxybutyrate as possible markers of amino acid and fatty acid catabolic pathways by LC-ESI-MS/MS. Springerplus 2015;4:494. [PMID: 26389019 DOI: 10.1186/s40064-015-1304-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
62 Saeki C, Kanai T, Nakano M, Oikawa T, Torisu Y, Saruta M, Tsubota A. Low Serum Branched-Chain Amino Acid and Insulin-Like Growth Factor-1 Levels Are Associated with Sarcopenia and Slow Gait Speed in Patients with Liver Cirrhosis. J Clin Med 2020;9:E3239. [PMID: 33050430 DOI: 10.3390/jcm9103239] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
63 Zhang G, Mandal R, Wishart DS, Ametaj BN. A Multi-Platform Metabolomics Approach Identifies Urinary Metabolite Signatures That Differentiate Ketotic From Healthy Dairy Cows. Front Vet Sci 2021;8:595983. [PMID: 33575283 DOI: 10.3389/fvets.2021.595983] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Abdelsayed GG. Diets in Encephalopathy. Clinics in Liver Disease 2015;19:497-505. [DOI: 10.1016/j.cld.2015.05.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
65 Chen SH, Wan QS, Wang T, Zhang KH. Fluid Biomarkers for Predicting the Prognosis of Liver Cirrhosis. Biomed Res Int 2020;2020:7170457. [PMID: 32280697 DOI: 10.1155/2020/7170457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Hanai T, Shiraki M, Watanabe S, Kochi T, Imai K, Suetsugu A, Takai K, Moriwaki H, Shimizu M. Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis. Hepatol Res. 2017;47:1359-1367. [PMID: 28199774 DOI: 10.1111/hepr.12873] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
67 Bellar A, Welch N, Dasarathy S. Exercise and physical activity in cirrhosis: opportunities or perils. J Appl Physiol (1985) 2020;128:1547-67. [PMID: 32240017 DOI: 10.1152/japplphysiol.00798.2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I, Shibuya A, Seike M, Nagoshi S, Segawa M, Tsubouchi H, Moriwaki H, Kato A, Hashimoto E, Michitaka K, Murawaki T, Sugano K, Watanabe M, Shimosegawa T. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol 2016;51:629-50. [PMID: 27246107 DOI: 10.1007/s00535-016-1216-y] [Cited by in Crossref: 181] [Cited by in F6Publishing: 163] [Article Influence: 30.2] [Reference Citation Analysis]
69 Meng J, Zhong J, Zhang H, Zhong W, Huang Z, Jin Y, Xu J. Pre-, peri-, and postoperative oral administration of branched-chain amino acids for primary liver cancer patients for hepatic resection: a systematic review. Nutr Cancer. 2014;66:517-522. [PMID: 24033366 DOI: 10.1080/01635581.2013.780628] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
70 Suzuki K, Endo R, Takikawa Y, Moriyasu F, Aoyagi Y, Moriwaki H, Terai S, Sakaida I, Sakai Y, Nishiguchi S, Ishikawa T, Takagi H, Naganuma A, Genda T, Ichida T, Takaguchi K, Miyazawa K, Okita K. Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator-blinded, active-controlled trial and a phase III, multicenter, open trial. Hepatol Res. 2018;48:411-423. [PMID: 29235218 DOI: 10.1111/hepr.13045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
71 Ishikawa T, Imai M, Ko M, Sato H, Nozawa Y, Sano T, Iwanaga A, Seki K, Honma T, Yoshida T. Evaluation of the branched-chain amino acid-to-tyrosine ratio prior to treatment as a prognostic predictor in patients with liver cirrhosis. Oncotarget 2017;8:79480-90. [PMID: 29108327 DOI: 10.18632/oncotarget.18447] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
72 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Kishino K, Shimono Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Ishii A, Iijima H, Nishiguchi S. Factors Associated With Protein-energy Malnutrition in Chronic Liver Disease: Analysis Using Indirect Calorimetry. Medicine (Baltimore) 2016;95:e2442. [PMID: 26765430 DOI: 10.1097/MD.0000000000002442] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
73 Mizuguchi T, Kawamoto M, Meguro M, Nakamura Y, Harada K, Kukita K, Hirata K. Prognostic impact of preoperative the branched-chain amino acid to the tyrosine ratio in hepatocellular carcinoma patients after initial hepatectomy. J Gastrointest Surg. 2011;15:1433-1439. [PMID: 21607795 DOI: 10.1007/s11605-011-1566-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
74 Takeda H, Nishikawa H, Iguchi E, Ohara Y, Sakamoto A, Saito S, Nishijima N, Nasu A, Komekado H, Kita R, Kimura T, Osaki Y. Effect of treatment with branched-chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma: BCAA during sorafenib therapy for HCC. Hepatol Res 2014;44:302-12. [DOI: 10.1111/hepr.12125] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
75 Kobayashi T, Kawai H, Nakano O, Abe S, Kamimura H, Sakamaki A, Kamimura K, Tsuchiya A, Takamura M, Yamagiwa S, Terai S. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies. BMC Cancer 2018;18:756. [PMID: 30041616 DOI: 10.1186/s12885-018-4673-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
76 Kawaoka T, Takahashi S, Aikata H, Azakami T, Saneto H, Takaki S, Jeong SC, Asahara T, Ito K, Chayama K. Beneficial effects of living-donor liver transplantation on esophageal varices. J Gastroenterol 2008;43:982-9. [DOI: 10.1007/s00535-008-2269-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
77 Okabayashi T, Nishimori I, Sugimoto T, Iwasaki S, Akisawa N, Maeda H, Ito S, Onishi S, Ogawa Y, Kobayashi M, Hanazaki K. The benefit of the supplementation of perioperative branched-chain amino acids in patients with surgical management for hepatocellular carcinoma: a preliminary study. Dig Dis Sci 2008;53:204-9. [PMID: 17510798 DOI: 10.1007/s10620-007-9844-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
78 Sridhar S, Botbol Y, Macian F, Cuervo AM. Autophagy and disease: always two sides to a problem. J Pathol 2012;226:255-73. [PMID: 21990109 DOI: 10.1002/path.3025] [Cited by in Crossref: 183] [Cited by in F6Publishing: 183] [Article Influence: 16.6] [Reference Citation Analysis]
79 Nishikawa H, Enomoto H, Yoh K, Iwata Y, Hasegawa K, Nakano C, Takata R, Kishino K, Shimono Y, Sakai Y, Nishimura T, Aizawa N, Ikeda N, Takashima T, Ishii A, Iijima H, Nishiguchi S. Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C. Medicine (Baltimore) 2016;95:e3920. [PMID: 27311000 DOI: 10.1097/MD.0000000000003920] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
80 Tada T, Kumada T, Toyoda H, Yasuda S, Koyabu T, Nakashima M. Impact of Branched-Chain Amino Acid Granule Therapy in Patients with Hepatocellular Carcinoma Who Have Normal Albumin Levels and Low Branched-Chain Amino Acid to Tyrosine Ratios. Nutr Cancer 2019;71:1132-41. [PMID: 30955354 DOI: 10.1080/01635581.2019.1597905] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
81 Garcia-Martinez R, Caraceni P, Bernardi M, Gines P, Arroyo V, Jalan R. Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology. 2013;58:1836-1846. [PMID: 23423799 DOI: 10.1002/hep.26338] [Cited by in Crossref: 189] [Cited by in F6Publishing: 152] [Article Influence: 21.0] [Reference Citation Analysis]
82 Ida S, Kojima Y, Hamaoka S, Urawa N, Araki J, Kaneko R, Murata K. Validity of Japanese version of SARC‐F questionnaire in patients with chronic liver disease. Journal of Gastroenterology and Hepatology 2018;34:947-53. [DOI: 10.1111/jgh.14449] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
83 Nagaoki Y, Aikata H, Kobayashi T, Fukuhara T, Masaki K, Tanaka M, Naeshiro N, Nakahara T, Honda Y, Miyaki D, Kawaoka T, Takaki S, Tsuge M, Hiramatsu A, Imamura M, Hyogo H, Kawakami Y, Takahashi S, Ochi H, Chayama K. Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosis. J Gastroenterol 2013;48:847-55. [PMID: 23053422 DOI: 10.1007/s00535-012-0679-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
84 Okabayashi T, Hanazaki K. Overwhelming postsplenectomy infection syndrome in adults - A clinically preventable disease. World J Gastroenterol 2008; 14(2): 176-179 [PMID: 18186551 DOI: 10.3748/wjg.14.176] [Cited by in CrossRef: 88] [Cited by in F6Publishing: 56] [Article Influence: 6.3] [Reference Citation Analysis]
85 Maki H, Yamanaka-Okumura H, Katayama T, Ozawa Y, Hosoda A, Kurata N, Amemiya F. Late evening snacks with branched-chain amino acids improve the Fischer ratio with patients liver cirrhosis at fasting in the next morning. Clin Nutr ESPEN. 2019;30:138-144. [PMID: 30904214 DOI: 10.1016/j.clnesp.2019.01.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
86 Ujiie N, Nakano T, Yamada M, Sato C, Nakanishi C, Fujishima F, Ito K, Shindo T, Shimokawa H, Kamei T. Low-energy extracorporeal shock wave therapy for a model of liver cirrhosis ameliorates liver fibrosis and liver function. Sci Rep 2020;10:2405. [PMID: 32051434 DOI: 10.1038/s41598-020-58369-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Cha JH, Bae SH, Kim HL, Park NR, Choi ES, Jung ES, Choi JY, Yoon SK. Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis. PLoS One. 2013;8:e77899. [PMID: 24223741 DOI: 10.1371/journal.pone.0077899] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
88 Ohara M, Ogawa K, Suda G, Kimura M, Maehara O, Shimazaki T, Suzuki K, Nakamura A, Umemura M, Izumi T, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ohnishi S, Sakamoto N. L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis. Hepatol Commun. 2018;2:906-918. [PMID: 30094402 DOI: 10.1002/hep4.1207] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
89 Sato S, Amano N, Sato S, Kita Y, Ikeda Y, Kabemura D, Murata A, Yatagai N, Tsuzura H, Shimada Y, Genda T. Elevated serum tyrosine concentration is associated with a poor prognosis among patients with liver cirrhosis. Hepatol Res 2021;51:786-95. [PMID: 33964118 DOI: 10.1111/hepr.13651] [Reference Citation Analysis]
90 Sakai Y, Nishikawa H, Enomoto H, Yoh K, Iwata Y, Hasegawa K, Nakano C, Kishino K, Shimono Y, Takata R, Nishimura T, Aizawa N, Ikeda N, Takashima T, Ishii A, Iijima H, Nishiguchi S. Effect of L-Carnitine in Patients With Liver Cirrhosis on Energy Metabolism Using Indirect Calorimetry: A Pilot Study. J Clin Med Res 2016;8:863-9. [PMID: 27829952 DOI: 10.14740/jocmr2734w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
91 Tamanna N, Mahmood N. Emerging Roles of Branched-Chain Amino Acid Supplementation in Human Diseases. Int Sch Res Notices 2014;2014:235619. [PMID: 27351005 DOI: 10.1155/2014/235619] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
92 Nakamura Y, Mizuguchi T, Kawamoto M, Meguro M, Harada K, Ota S, Hirata K. Cluster analysis of indicators of liver functional and preoperative low branched-chain amino acid tyrosine ration indicate a high risk of early recurrence in analysis of 165 hepatocellular carcinoma patients after initial hepatectomy. Surgery. 2011;150:250-262. [PMID: 21801962 DOI: 10.1016/j.surg.2011.06.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
93 Kawanaka M, Nishino K, Oka T, Urata N, Nakamura J, Suehiro M, Kawamoto H, Chiba Y, Yamada G. Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease. Hepat Med 2015;7:29-35. [PMID: 26082668 DOI: 10.2147/HMER.S79100] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
94 Kaibori M, Ishizaki M, Matsui K, Nakatake R, Sakaguchi T, Habu D, Yoshiuchi S, Kimura Y, Kon AH. Assessment of preoperative exercise capacity in hepatocellular carcinoma patients with chronic liver injury undergoing hepatectomy. BMC Gastroenterol 2013;13:119. [PMID: 23875788 DOI: 10.1186/1471-230X-13-119] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
95 Kudo M. Molecular targeted therapy for hepatocellular carcinoma: bench to bedside. Dig Dis. 2011;29:273-277. [PMID: 21829017 DOI: 10.1159/000327558] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
96 Haraguchi M, Ichinose K, Miyaaki H, Hanada M, Fukushima M, Sasaki R, Miuma S, Hara T, Kugiyama T, Soyama A, Hidaka M, Tsuji A, Yano R, Sekino M, Takahata H, Eguchi S, Nakao K. Comparative study of the effect of neuromuscular electrical stimulation and oral administration of branched-chain amino acid on preventing sarcopenia in patients after living-donor liver transplantation: study protocol for an open-label randomized controlled trial. Trials 2021;22:137. [PMID: 33579345 DOI: 10.1186/s13063-021-05086-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Amano N, Ikeda Y, Hayashida S, Takahashi S, Sato S, Murata A, Tsuzura H, Sato S, Shimada Y, Iijima K, Wada R, Nagahara A, Genda T. Prognostic significance of serum tyrosine concentration in patients with primary biliary cholangitis under ursodeoxycholic acid therapy. Hepatol Res 2020;50:214-23. [PMID: 31652380 DOI: 10.1111/hepr.13434] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
98 Sakai H, Shirakami Y, Shimizu M. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents. World J Gastroenterol 2016; 22(1): 394-406 [PMID: 26755885 DOI: 10.3748/wjg.v22.i1.394] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
99 Ishikawa T. Early administration of branched-chain amino acid granules. World J Gastroenterol 2012; 18(33): 4486-4490 [PMID: 22969221 DOI: 10.3748/wjg.v18.i33.4486] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
100 Kawaguchi T, Shiraishi K, Ito T, Suzuki K, Koreeda C, Ohtake T, Iwasa M, Tokumoto Y, Endo R, Kawamura NH. Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis. Clin Gastroenterol Hepatol. 2014;12:1012-1018.e1. [PMID: 24036055 DOI: 10.1016/j.cgh.2013.08.050] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 5.7] [Reference Citation Analysis]
101 Ohara M, Suda G, Kimura M, Maehara O, Shimazaki T, Shigesawa T, Suzuki K, Nakamura A, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Kobayashi T, Uebayashi M, Takagi R, Yokota I, Shimamura T, Sakamoto N. Analysis of the optimal psoas muscle mass index cut-off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people. Hepatol Res 2020;50:715-25. [PMID: 32202371 DOI: 10.1111/hepr.13499] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
102 Nishikawa H, Osaki Y. Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis. Mediators Inflamm. 2015;2015:872152. [PMID: 26494949 DOI: 10.1155/2015/872152] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
103 Zheng H, Chen M, Lu S, Zhao L, Ji J, Gao H. Metabolic characterization of hepatitis B virus-related liver cirrhosis using NMR-based serum metabolomics. Metabolomics 2017;13. [DOI: 10.1007/s11306-017-1260-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
104 Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabatake S, Niinomi T, Ito T. Oral supplementation with branched-chain amino acid granules prevents hepatocarcinogenesis in patients with hepatitis C-related cirrhosis: A propensity score analysis. Hepatol Res. 2013;Epub ahead of print. [PMID: 23607436 DOI: 10.1111/hepr.12120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
105 Nishikawa H, Enomoto H, Nishiguchi S, Iijima H. Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact. Int J Mol Sci 2021;22:1917. [PMID: 33671926 DOI: 10.3390/ijms22041917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
106 Choo AY, Kim SG, Vander Heiden MG, Mahoney SJ, Vu H, Yoon SO, Cantley LC, Blenis J. Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. Mol Cell 2010;38:487-99. [PMID: 20513425 DOI: 10.1016/j.molcel.2010.05.007] [Cited by in Crossref: 192] [Cited by in F6Publishing: 182] [Article Influence: 16.0] [Reference Citation Analysis]
107 Saeki C, Kanai T, Nakano M, Oikawa T, Torisu Y, Saruta M, Tsubota A. Clinical characteristics of sarcopenia in patients with alcoholic liver cirrhosis. JGH Open 2021;5:763-9. [PMID: 34263070 DOI: 10.1002/jgh3.12582] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Shimizu M, Tanaka T, Moriwaki H. Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis. Semin Immunopathol. 2013;35:191-202. [PMID: 22945457 DOI: 10.1007/s00281-012-0336-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
109 Ikeda T, Aizawa J, Nagasawa H, Gomi I, Kugota H, Nanjo K, Jinno T, Masuda T, Morita S. Effects and feasibility of exercise therapy combined with branched-chain amino acid supplementation on muscle strengthening in frail and pre-frail elderly people requiring long-term care: a crossover trial. Appl Physiol Nutr Metab 2016;41:438-45. [DOI: 10.1139/apnm-2015-0436] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
110 Lee M, Kim K. Innovative and practical conditioning beverages for public health and athletic performance: Focus on immunopotentiation by lactic acid bacteria B240. J Exerc Nutrition Biochem 2019;23:13-5. [PMID: 31337200 DOI: 10.20463/jenb.2019.0011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
111 Takaguchi K, Moriwaki H, Doyama H, Iida M, Yagura M, Shimada N, Kang M, Yamada H, Kumada H. Effects of branched-chain amino acid granules on serum albumin level and prognosis are dependent on treatment adherence in patients with liver cirrhosis. Hepatol Res 2013;43:459-66. [PMID: 23046471 DOI: 10.1111/j.1872-034X.2012.01097.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
112 Luan H, Liu LF, Tang Z, Zhang M, Chua KK, Song JX, Mok VC, Li M, Cai Z. Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease. Sci Rep 2015;5:13888. [PMID: 26365159 DOI: 10.1038/srep13888] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 11.0] [Reference Citation Analysis]
113 Biliotti E, Giampaoli O, Sciubba F, Marini F, Tomassini A, Palazzo D, Capuani G, Esvan R, Spaziante M, Taliani G, Miccheli A. Urinary metabolomics of HCV patients with severe liver fibrosis before and during the sustained virologic response achieved by direct acting antiviral treatment. Biomed Pharmacother 2021;143:112217. [PMID: 34560544 DOI: 10.1016/j.biopha.2021.112217] [Reference Citation Analysis]
114 Hayashi F, Kaibori M, Sakaguchi T, Matsui K, Ishizaki M, Kwon AH, Iwasaka J, Kimura Y, Habu D. Loss of skeletal muscle mass in patients with chronic liver disease is related to decrease in bone mineral density and exercise tolerance. Hepatol Res 2018;48:345-54. [PMID: 29115721 DOI: 10.1111/hepr.13000] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
115 Nishikawa H, Osaki Y. Clinical significance of therapy using branched-chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma. Hepatol Res. 2014;44:149-158. [PMID: 23819582 DOI: 10.1111/hepr.12194] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
116 Hiraoka A, Kato M, Marui K, Murakami T, Onishi K, Adachi T, Matsuoka J, Ueki H, Yoshino T, Tsuruta M, Aibiki T, Okudaira T, Kuroda T, Iwasaki R, Suga Y, Miyata H, Ninomiya T, Hirooka M, Abe M, Matsuura B, Michitaka K, Hiasa Y. Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker. Cancer Med 2021;10:3584-92. [PMID: 33960691 DOI: 10.1002/cam4.3908] [Reference Citation Analysis]